KURZWEIL RAY

CIK: 0001108501
Director

KURZWEIL RAY is a corporate insider at UNITED THERAPEUTICS Corp (UTHR) filing SEC Form 4 transactions. 181 transactions across 2 companies, totaling $0 in purchases and $18,781,349 in sales. Source: SEC EDGAR.

AI Insider Summary

Ray Kurzweil's Form 4 record at United Therapeutics Corp spans 174 transactions since May 2004, all sales or option-related, totaling 268,430 shares with zero open-market purchases. The standout event is a single day, February 28, 2025: Kurzweil exercised 30,000 options at a $175.43 strike price (two 15,000-share tranches), then sold exactly 15,000 shares that same day across nine separate transactions, at prices ranging from $314.25 to $323.53 — a spread of roughly $139 to $148 per share captured in a single session. A year earlier, on February 23, 2024, a different combination played out: two 15,000-share option exercises (one at an $88.03 strike, one with no price recorded) alongside a 15,000-share disposition transaction (code D) at $227.03. Kurzweil's more routine activity follows an annual July pattern — small option exercises (650 or 900 shares, exercised in pairs) and stock-award grants (590 to 1,830 shares) recurring most years since at least 2023, most recently a pair of 650-share exercises on July 9, 2026. A separate, older relationship at Inforte Corp, active from April 2004 to April 2007, shows 5 transactions totaling 6,061 shares sold, with no purchases.

A year before that, on February 23, 2024, a different combination of transactions appeared: two more 15,000-share option exercises — one at an $88.03 strike price, one with no price recorded — alongside a 15,000-share disposition transaction (transaction code D, distinct from an open-market sale) priced at $227.03.

Outside of those two large February events, Kurzweil's activity follows a smaller, recurring July pattern. Small option exercises of 650 or 900 shares, typically executed in matching pairs, and stock-award grants ranging from 590 to 1,830 shares appear most years going back to at least 2023 — most recently a pair of 650-share exercises on July 9, 2026, following similar pairs in July 2025 and July 2024.

Analysis generated by 13F Insight from SEC Form 4 filing data. Methodology
Total Transactions
181
Total Buy Value
$0
Total Sell Value
$18.78M
Net Activity
$-18.78M
Last Transaction
Jul 2026
Companies
2

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Award
Shares
1,190
Price
$527.07
Value
$627K
Type
Award
Shares
380
Price
-
Value
-
Type
Exercise
Shares
650
Price
-
Value
-
Type
Exercise
Shares
650
Price
-
Value
-
Type
Exercise
Shares
590
Price
-
Value
-
Type
Exercise
Shares
590
Price
-
Value
-
Type
Award
Shares
1,830
Price
-
Value
-
Type
Award
Shares
650
Price
-
Value
-
Type
Exercise
Shares
15,000
Price
$175.43
Value
$2.63M
Type
Sale
Shares
100
Price
$323.53
Value
$32K
Type
Sale
Shares
750
Price
$322.43
Value
$242K
Type
Sale
Shares
1,095
Price
$321.53
Value
$352K
Type
Sale
Shares
1,519
Price
$320.43
Value
$487K
Type
Sale
Shares
1,303
Price
$318.28
Value
$415K
Type
Sale
Shares
897
Price
$317.33
Value
$285K
Type
Sale
Shares
2,256
Price
$316.07
Value
$713K
Type
Sale
Shares
4,821
Price
$315.26
Value
$1.52M
Type
Sale
Shares
2,259
Price
$314.25
Value
$710K
Type
Exercise
Shares
15,000
Price
$175.43
Value
$2.63M
Type
Award
Shares
590
Price
-
Value
-